MORPHINE SULFATE INJECTION
MORPHINE SULFATE INJECTION
Approved
DIN Number
02500728
Drug Class
Human
Market Date
Apr 29, 2021
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02500728
AIG Number0104545001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
,
Subcutaneous
,
Intravenous
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MORPHINE SULFATEActive
Strength: 10 MG / ML
Monograph: MORPHINE SULFATE